Support the people of Hawaiʻi by providing enhanced capacity for the diagnosis of neglected tropical diseases and in times of crisis serve as a resource to augment public health response efforts.
- Through enhanced testing capacity for COVID-19, the CLIA-certified laboratory at JABSOM, would complement and support public health countermeasures (e.g.contact tracing) to benefit the state.
- Coordinate UH’s considerable human resources and expertise in virology, bacteriology, parasitology, and immunology to support the people of Hawai‘i in pandemic response.
- Make antibody tests available so that individuals know whether they knowingly or unknowingly contracted COVID-19 and have subsequently recovered. These individuals may be eligible to return to work safely.
- Conduct retrospective and prospective sero-surveillance studies. This research will enable State epidemiologists to accurately estimate the impact of medically important infectious diseases.
- Complement and support Department of Health and other local diagnostic testing facilities by providing capacity for the diagnosis of neglected tropical diseases, such as rat lungworm disease, leptospirosis, murine typhus and toxoplasmosis, which greatly affect the people of Hawai‘i.
- In the long-term, provide added value to public health in Hawaiʻi by responding to infectious disease threats , including but not limited to influenza and mosquito-borne flaviviruses (such as dengue, West Nile, and Zika) and alphaviruses (such as chikungunya).